Average Co-Inventor Count = 5.54
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agouron Pharmaceuticals, Inc. (7 from 174 patents)
2. Other (2 from 832,680 patents)
3. Japan Tobacco Inc. (2 from 1,037 patents)
4. Effector Therapeutics, Inc. (2 from 21 patents)
5. Cancer Research Technology Limited (1 from 262 patents)
6. Strategic Enzyme Applications, Inc. (1 from 2 patents)
7. Stragegic Enzyme Applications, Inc. (1 from 1 patent)
8. Agouron Phramaceuticals, Inc. (1 from 1 patent)
14 patents:
1. 11952375 - Crystalline forms of Mnk inhibitors
2. 11130757 - Crystalline forms of MNK inhibitors
3. 9683001 - Process of producing phosphinothricin employing nitrilases
4. 8981142 - Process of producing phosphinothricin employing nitrilases
5. 7268126 - Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one
6. 6472534 - Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
7. 6465661 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
8. 6403799 - Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors
9. 6392067 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
10. 6316625 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
11. 6117999 - Methods of making HIV-protease inhibitors and intermediates for making
12. 6084107 - Intermediates for making HIV-protease inhibitors
13. 5925759 - Methods of making HIV-protease inhibitors and intermediates for making
14. 5705647 - Intermediates for making HIV-protease inhibitors